Hood River Capital Management LLC Has $55.72 Million Stake in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Hood River Capital Management LLC boosted its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 39.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,952,995 shares of the company's stock after buying an additional 1,405,212 shares during the period. Hood River Capital Management LLC owned about 2.58% of Alignment Healthcare worth $55,721,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Rhumbline Advisers boosted its position in shares of Alignment Healthcare by 2.2% during the 4th quarter. Rhumbline Advisers now owns 135,704 shares of the company's stock valued at $1,527,000 after acquiring an additional 2,937 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in Alignment Healthcare by 5.6% during the fourth quarter. MetLife Investment Management LLC now owns 61,344 shares of the company's stock valued at $690,000 after purchasing an additional 3,256 shares in the last quarter. Alliancebernstein L.P. grew its stake in shares of Alignment Healthcare by 2.8% in the 4th quarter. Alliancebernstein L.P. now owns 119,440 shares of the company's stock valued at $1,344,000 after purchasing an additional 3,300 shares during the period. R Squared Ltd bought a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $55,000. Finally, SG Americas Securities LLC lifted its position in shares of Alignment Healthcare by 11.7% during the 4th quarter. SG Americas Securities LLC now owns 49,272 shares of the company's stock worth $554,000 after buying an additional 5,163 shares during the period. Institutional investors own 86.19% of the company's stock.

Analysts Set New Price Targets

ALHC has been the subject of a number of research analyst reports. Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th. Robert W. Baird boosted their price objective on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. Barclays raised their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research note on Friday, February 28th. Bank of America upped their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research report on Tuesday, March 4th. Finally, Stephens restated an "overweight" rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research report on Monday, February 24th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $16.61.

Alignment Healthcare Trading Up 3.8 %

NASDAQ ALHC opened at $18.16 on Wednesday. Alignment Healthcare, Inc. has a 12 month low of $4.92 and a 12 month high of $21.06. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a 50 day moving average of $16.69 and a 200-day moving average of $13.96. The company has a market cap of $3.48 billion, a PE ratio of -23.58 and a beta of 1.32.

Insiders Place Their Bets

In other Alignment Healthcare news, COO Sebastian Burzacchi sold 6,694 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total transaction of $109,781.60. Following the transaction, the chief operating officer now owns 250,378 shares of the company's stock, valued at $4,106,199.20. The trade was a 2.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hakan Kardes sold 14,500 shares of Alignment Healthcare stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $14.98, for a total value of $217,210.00. Following the transaction, the insider now owns 295,444 shares of the company's stock, valued at $4,425,751.12. This represents a 4.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,171,355 shares of company stock valued at $34,961,517. 6.60% of the stock is currently owned by corporate insiders.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.